apixabanVKADOACDOAC-antiplateletAtrial fibrillation
…e majority (64.4%) of patients received reduced DOAC doses with apixaban prescribed in 40.7%. In 39 (14.4%) patients, antithrombotic use…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: DOAC-antiplatelet ×
DOAC-antiplatelet
This drug is selected. Its supporting articles are shown below.